PBF vs REGN · P/E 10.0, rev $33.12B vs P/E 14, rev $14.34B
PBF Energy Inc (PBF) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
PBF Energy Inc (PBF) is a oil & gas refining & marketing company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PBF revenue for 2024-12-31 was $33.12B. Net income was -$540.2M. Revenue was down 13.6% from 2023-12-31 to 2024-12-31. PBF currently screens at market cap $4.47B and trailing P/E 10.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PBF currently screens at market cap $4.47B and trailing P/E 10.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PBF and REGN stock pages for the full models.
Not investment advice.